Optical molecular imaging approach for rapid assessment of response of individual cancer cells to chemotherapy

Zhen Luo, Rohan Vijay Tikekar, Kiana Michelle Samadzadeh, Nitin Nitin

Research output: Contribution to journalArticle

6 Citations (Scopus)

Abstract

Predicting the response of individual patients to cytotoxic chemotherapy drugs is critical for developing individualized therapies. With this motivation, an optical molecular imaging approach was developed to detect cisplatin induced changes in the uptake and intracellular retention of choline. Intracellular uptake of choline was characterized using a click chemistry reaction between propargyl choline and Alexa-488 azide. Cisplatin induced changes in the uptake of propargyl choline in cells and tumor spheroids were compared with similar measurements using a fluorescent analogue of deoxyglucose and conventional cell viability assays. Uptake and intracellular retention of propargyl choline decreased with an increase in concentration of cisplatin. Intracellular uptake of propargyl choline was significantly reduced within 3 h of incubation with a sub-lethal dose of cisplatin. Results demonstrate that the imaging approach based on propargyl choline was more sensitive in detecting the early response of cancer cells to cisplatin as compared to the imaging based on fluorescent analogue of deoxyglucose and cell viability assays. Imaging measurements in tumor spheroids show a significant decrease in the uptake of propargyl choline following treatment with cisplatin. Overall, the results demonstrate a novel optical molecular imaging approach for rapid measurement of the response of individual cancer cells to cisplatin treatment.

Original languageEnglish (US)
Article number106006
JournalJournal of Biomedical Optics
Volume17
Issue number10
DOIs
StatePublished - Oct 2012

Fingerprint

Molecular imaging
choline
Chemotherapy
chemotherapy
Choline
Cisplatin
cancer
Cells
spheroids
Deoxyglucose
Imaging techniques
viability
Tumors
Assays
tumors
analogs
Azides
therapy
drugs
chemistry

Keywords

  • Fluorescence
  • Imaging
  • Materials
  • Medical imaging

ASJC Scopus subject areas

  • Biomedical Engineering
  • Biomaterials
  • Electronic, Optical and Magnetic Materials
  • Atomic and Molecular Physics, and Optics

Cite this

Optical molecular imaging approach for rapid assessment of response of individual cancer cells to chemotherapy. / Luo, Zhen; Tikekar, Rohan Vijay; Samadzadeh, Kiana Michelle; Nitin, Nitin.

In: Journal of Biomedical Optics, Vol. 17, No. 10, 106006, 10.2012.

Research output: Contribution to journalArticle

Luo, Zhen ; Tikekar, Rohan Vijay ; Samadzadeh, Kiana Michelle ; Nitin, Nitin. / Optical molecular imaging approach for rapid assessment of response of individual cancer cells to chemotherapy. In: Journal of Biomedical Optics. 2012 ; Vol. 17, No. 10.
@article{268862be66dd441eb59761aaf1043cc6,
title = "Optical molecular imaging approach for rapid assessment of response of individual cancer cells to chemotherapy",
abstract = "Predicting the response of individual patients to cytotoxic chemotherapy drugs is critical for developing individualized therapies. With this motivation, an optical molecular imaging approach was developed to detect cisplatin induced changes in the uptake and intracellular retention of choline. Intracellular uptake of choline was characterized using a click chemistry reaction between propargyl choline and Alexa-488 azide. Cisplatin induced changes in the uptake of propargyl choline in cells and tumor spheroids were compared with similar measurements using a fluorescent analogue of deoxyglucose and conventional cell viability assays. Uptake and intracellular retention of propargyl choline decreased with an increase in concentration of cisplatin. Intracellular uptake of propargyl choline was significantly reduced within 3 h of incubation with a sub-lethal dose of cisplatin. Results demonstrate that the imaging approach based on propargyl choline was more sensitive in detecting the early response of cancer cells to cisplatin as compared to the imaging based on fluorescent analogue of deoxyglucose and cell viability assays. Imaging measurements in tumor spheroids show a significant decrease in the uptake of propargyl choline following treatment with cisplatin. Overall, the results demonstrate a novel optical molecular imaging approach for rapid measurement of the response of individual cancer cells to cisplatin treatment.",
keywords = "Fluorescence, Imaging, Materials, Medical imaging",
author = "Zhen Luo and Tikekar, {Rohan Vijay} and Samadzadeh, {Kiana Michelle} and Nitin Nitin",
year = "2012",
month = "10",
doi = "10.1117/1.JBO.17.10.106006",
language = "English (US)",
volume = "17",
journal = "Journal of Biomedical Optics",
issn = "1083-3668",
publisher = "SPIE",
number = "10",

}

TY - JOUR

T1 - Optical molecular imaging approach for rapid assessment of response of individual cancer cells to chemotherapy

AU - Luo, Zhen

AU - Tikekar, Rohan Vijay

AU - Samadzadeh, Kiana Michelle

AU - Nitin, Nitin

PY - 2012/10

Y1 - 2012/10

N2 - Predicting the response of individual patients to cytotoxic chemotherapy drugs is critical for developing individualized therapies. With this motivation, an optical molecular imaging approach was developed to detect cisplatin induced changes in the uptake and intracellular retention of choline. Intracellular uptake of choline was characterized using a click chemistry reaction between propargyl choline and Alexa-488 azide. Cisplatin induced changes in the uptake of propargyl choline in cells and tumor spheroids were compared with similar measurements using a fluorescent analogue of deoxyglucose and conventional cell viability assays. Uptake and intracellular retention of propargyl choline decreased with an increase in concentration of cisplatin. Intracellular uptake of propargyl choline was significantly reduced within 3 h of incubation with a sub-lethal dose of cisplatin. Results demonstrate that the imaging approach based on propargyl choline was more sensitive in detecting the early response of cancer cells to cisplatin as compared to the imaging based on fluorescent analogue of deoxyglucose and cell viability assays. Imaging measurements in tumor spheroids show a significant decrease in the uptake of propargyl choline following treatment with cisplatin. Overall, the results demonstrate a novel optical molecular imaging approach for rapid measurement of the response of individual cancer cells to cisplatin treatment.

AB - Predicting the response of individual patients to cytotoxic chemotherapy drugs is critical for developing individualized therapies. With this motivation, an optical molecular imaging approach was developed to detect cisplatin induced changes in the uptake and intracellular retention of choline. Intracellular uptake of choline was characterized using a click chemistry reaction between propargyl choline and Alexa-488 azide. Cisplatin induced changes in the uptake of propargyl choline in cells and tumor spheroids were compared with similar measurements using a fluorescent analogue of deoxyglucose and conventional cell viability assays. Uptake and intracellular retention of propargyl choline decreased with an increase in concentration of cisplatin. Intracellular uptake of propargyl choline was significantly reduced within 3 h of incubation with a sub-lethal dose of cisplatin. Results demonstrate that the imaging approach based on propargyl choline was more sensitive in detecting the early response of cancer cells to cisplatin as compared to the imaging based on fluorescent analogue of deoxyglucose and cell viability assays. Imaging measurements in tumor spheroids show a significant decrease in the uptake of propargyl choline following treatment with cisplatin. Overall, the results demonstrate a novel optical molecular imaging approach for rapid measurement of the response of individual cancer cells to cisplatin treatment.

KW - Fluorescence

KW - Imaging

KW - Materials

KW - Medical imaging

UR - http://www.scopus.com/inward/record.url?scp=84876540098&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84876540098&partnerID=8YFLogxK

U2 - 10.1117/1.JBO.17.10.106006

DO - 10.1117/1.JBO.17.10.106006

M3 - Article

VL - 17

JO - Journal of Biomedical Optics

JF - Journal of Biomedical Optics

SN - 1083-3668

IS - 10

M1 - 106006

ER -